Interestingly, in this in vivo model of NASH-related liver fibrosis the expression of NOX2 gene was significantly reduced in HXT + VitE-treated WD-fed mice compared to WD-fed control mice group (Figure 4F). This evidence concerns the gene CYBB and metabolic dysfunction-associated steatohepatitis.